We are live on
!
Find out more
CF
Corebridge Financial Portfolio holdings
AUM
$1.09B
1-Year Est. Return
1.85%
This Fund
S&P 500
This Quarter
Est. Return
+1%
1 Year Est. Return
-1.85%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$449M
AUM Growth
-$16.9B
(-97%)
Cap. Flow
-$16.9B
Cap. Flow
% of AUM
-3,777.67%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3,015
New
1
Increased
–
Reduced
1
Closed
3,011
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Janus Henderson AAA CLO ETF
JAAA
|
+$49.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$851M |
| 2 |
Microsoft
MSFT
|
+$755M |
| 3 |
NVIDIA
NVDA
|
+$732M |
| 4 |
Amazon
AMZN
|
+$467M |
| 5 |
Meta Platforms (Facebook)
META
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Utilities | 0% |
| 2 | Consumer Discretionary | 0% |
| 3 | Consumer Staples | 0% |
| 4 | Energy | 0% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Akebia Therapeutics
AKBA
$338M
| – | – |
-106,085
| Closed | -$204K |
|
102
Acadia Realty Trust
AKR
$3.04B
| – | – |
-61,270
| Closed | -$1.28M |
|
|
AKRO
103
DELISTED
Akero Therapeutics
AKRO
| – | – |
-36,523
| Closed | -$1.48M |
|
|
AKYA
104
DELISTED
Akoya BioSciences
AKYA
| – | – |
-13,017
| Closed | -$18.1K |
|
|
AL
105
DELISTED
Air Lease Corp
AL
| – | – |
-4,046
| Closed | -$195K |
|
106
Albemarle
ALB
$13.5B
| – | – |
-27,012
| Closed | -$1.95M |
|
107
Alico
ALCO
$282M
| – | – |
-3,481
| Closed | -$104K |
|
108
Aldeyra Therapeutics
ALDX
$95.9M
| – | – |
-24,406
| Closed | -$140K |
|
|
ALE
109
DELISTED
Allete
ALE
| – | – |
-92,018
| Closed | -$6.05M |
|
110
Alector
ALEC
$171M
| – | – |
-40,171
| Closed | -$49.4K |
|
|
ALEX
111
DELISTED
Alexander & Baldwin
ALEX
| – | – |
-38,006
| Closed | -$655K |
|
112
Alamo Group
ALG
$1.92B
| – | – |
-5,354
| Closed | -$954K |
|
113
Allegro MicroSystems
ALGM
$8.19B
| – | – |
-144,303
| Closed | -$3.63M |
|
114
Align Technology
ALGN
$13B
| – | – |
-16,640
| Closed | -$2.64M |
|
115
Allegiant Air
ALGT
$2.64B
| – | – |
-8,060
| Closed | -$416K |
|
116
Alignment Healthcare
ALHC
$3.76B
| – | – |
-49,035
| Closed | -$913K |
|
117
Alight
ALIT
$546M
| – | – |
-10,280
| Closed | -$1.22M |
|
118
Alaska Air
ALK
$5.22B
| – | – |
-135,942
| Closed | -$6.69M |
|
119
Alkermes
ALKS
$8.05B
| – | – |
-84,142
| Closed | -$2.78M |
|
120
Alkami Technology
ALKT
$1.97B
| – | – |
-29,714
| Closed | -$780K |
|
121
Allstate
ALL
$70.4B
| – | – |
-61,324
| Closed | -$12.7M |
|
122
Allegion
ALLE
$13.5B
| – | – |
-20,626
| Closed | -$2.69M |
|
123
Allogene Therapeutics
ALLO
$639M
| – | – |
-62,887
| Closed | -$91.8K |
|
124
Ally Financial
ALLY
$13.4B
| – | – |
-303,991
| Closed | -$11.1M |
|
125
Alnylam Pharmaceuticals
ALNY
$38B
| – | – |
-2,128
| Closed | -$575K |
|
Similar funds
MIA
KCM
PWA
SI
DAM
PHS
ACP
MAM
Corebridge Financial's Q2 2025 Portfolio in Review
As of Q2 2025, Corebridge Financial held 3,015 positions worth $449M, down 97% from $17.4B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Corebridge Financial withdrew a net $16.9B in Q2 2025, closing 3,011 positions and reducing 1 holding. Its most notable exit was Apple, an estimated $851M position sold in full.
By sector, the portfolio is most concentrated in Utilities at 0% of assets, down from 2.5% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
Against the trend, Corebridge Financial opened a new position in Janus Henderson AAA CLO ETF worth $50M.
- Corebridge Financial's largest Q2 2025 buy was Janus Henderson AAA CLO ETF: 986,000 shares worth $50M.
- Corebridge Financial's biggest Q2 2025 reduction was NRG Energy, cutting an estimated $6.63M.
- Corebridge Financial fully exited Apple in Q2 2025, selling an estimated $851M.
- Corebridge Financial's ten largest holdings make up 100% of its $449M portfolio in Q2 2025.
- Corebridge Financial opened 1 new position and closed 3,011 in Q2 2025.
- Corebridge Financial's portfolio value fell 97% quarter-over-quarter to $449M.
Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.